The number and shape of limb tendons vary along the proximodistal axis, and the autopod contains more tendons than the zeugopod. The transcription factor Six2 is expressed in the developing tendons, and its expression can be traced back to a group of limb mesenchymal cells that are thought to be tendon precursor cells. We tried to elucidate the mechanism controlling position-specific tendon pattern formation using Six2 as a tendon marker. Six2 expression was always found in cells between the limb cartilage and ectoderm. Administration of BMP-2 or BMP antagonist Noggin to the limb bud, respectively repressed or facilitated Six2 expression. Removal of the ectoderm or administration of the Wnt antagonist sFRP-2 abolished Six2 expression and ectopic Wnt expression induced ectopic Six2 expression. Taken together, Six2 expression is induced in the cells located at the point where cartilage-derived Noggin and ectoderm-derived Wnt signals meet. Misexpression of the autopod-specific Hoxa-13 or Hoxd-13 induced ectopic expression of Six2 in the zeugopodal mesenchymal cells of the chick limb bud. Six2 expression in the dorsal autopodal mesenchyme was not detected in Hoxa-13
Introduction
During organogenesis, constituent tissues develop with ordered spatiotemporal patterns and make physical and functional connections with each other. In this process, the tissues that form earlier often play important roles in subsequent tissue patterning. In this process, two distinct mechanisms would be essential. One is the mechanism that determines the differentiation fate of the stem cells or precursor cells based upon their relative position in the organ primordium and upon the stage of organogenesis. The other is a mechanism that controls position-specific morphologies through control of cell proliferation, migration and adhesion.
The locomotor system of the limb consists of bone and muscle, as well as the tendon and ligament that connect them physically and functionally. These tissues have position-specific morphologies along the dorsoventral (D-V) and proximodistal (P-D) axes. Bone develops from the cartilaginous primordium in the limb. Cartilage, tendon, ligament, and fascia originate from the limb mesenchyme. In contrast, the limb muscle is derived from muscle mass, the cells migrating from the somites. These basic tissues having different origins or different developmental timing coordinately construct the functional locomotor system.
Among the mechanisms of pattern formation in mesenchymederived tissues, those of cartilage are the best understood. Cartilage pattern formation takes place autonomously in the limb mesenchyme under the control of a positional specification system consisting of the Hox genes. In the developing central nervous system, somites, lateral plate mesoderm and digestive tract, Hox genes are expressed sequentially along the anteroposterior (A-P) axis according to their order in the Hox clusters, and the Hox code determines positional specificity prior to position-specific tissue formation (Krumlauf, 1994; Sakiyama et al., 2001; Yokouchi et al., 1995b) . In the limb mesenchyme, the Abd-B genes belonging to the Hoxa or Hoxd cluster are expressed in a nested fashion along the P-D or the A-P axes (Nelson et al., 2006; Yokouchi et al., 1991a) . Gain-of-function and loss-of-function of Hox genes result in defective or altered skeletal patterns in the limb (Yokouchi et al., 1995a; Goff and Tabin, 1997; Fromental-Ramain et al., 1996; Zakany et al., 1997) affects the adhesiveness of mesenchymal cells and promotes a position-specific precartilaginous condensation pattern (Yokouchi et al., 1995a) .
In muscle development, sequential splitting of the migrating muscle mass results in position-specific muscle pattern. Prior to splitting, several Hox genes are expressed in the muscle mass in a position-specific manner (Yamamoto et al., 1998) , and Hox expression is regulated by interaction with the limb mesenchyme via soluble signaling molecules (Hashimoto et al., 1999) . Hox genes then regulate gene expression that controls muscle differentiation (Yamamoto and Kuroiwa, 2003) .
Tendon and ligament connect cartilage and muscle or cartilage and cartilage, respectively. For establishment of the correct positional relationships, coordination between precursor mesenchyme and the earlier-formed tissues, such as cartilage and ectoderm, is essential. A genetic system for tendon development was studied using the transcription factor Scleraxis (Scx) as a marker. Scx expression is induced around the muscle mass, extends distally and elongates along the digits. For Scx expression, cartilage functions via Noggin, a bone morphogenic protein (BMP) antagonist, and limb ectoderm is essential (Schweitzer et al., 2001 ). However, the ectodermal inductive factors have not yet been identified. At the developmental stage when tendon connects the skeletal element and muscle, Fgfs and Tgf-beta play crucial roles (Edom-Vovard et al., 2001; Edom-Vovard et al., 2002; Pryce et al., 2009) .
Tendons vary in number and morphology along the P-D axis of the limb. In hindlimb, the tendons of zeugopodal muscles have insertion sites on the distal autopodal skeletal elements. Although they show very simple string-like morphologies in the zeugopod, they intricately bifurcate in the autopod. In addition, many shorter tendons of the metatarsal muscles, including the abductors, adductors, and extensors, also exist in the autopod (Baumel et al., 1993; Greene, 1963) . Therefore, there are more tendons, in number, in the autopod than in the zeugopod. So it is possible that there is a unique mechanism for autopodal tendon formation, and the best candidate for involvement in this mechanism is the Hox system.
In the present study, we aimed to clarify the mechanisms of position-specific tendon precursor formation in the limb. For this purpose, we focused on the regulatory mechanisms of expression of the tendon-related gene Six2. Six2 is a member of the Six (sine oculisrelated homeobox) gene family, which contains the vertebrate homologues of the Drosophila eye gene sine oculis (Cheyette et al., 1994) . A previous report suggested that Six2 is a specific marker for the tendon precursor and tendon in the mouse limb (Oliver et al., 1995) . In this report, we first show that Six2 expression marks the tendon precursor and tendon during chick limb development. Then we show regulation of Six2 expression by Noggin from the cartilage and Wnts from the ectoderm. Finally we show that Hoxa-13 and Hoxd-13, autopodspecific Hox genes, regulate Six2 expression in the autopodal tendon precursor in cooperation with cartilage-and ectoderm-derived factors.
Materials and methods

Mouse embryos
Mice mutant for Hoxa-13 (Fromental-Ramain et al., 1996) and HoxD del mice (Zakany et al., 1997) ;HoxD þ /del double heterozygote mice. Genotyping was carried out by PCR methods using yolk sac-derived DNA.
Chicken embryos
Fertilized chicken eggs were purchased from Gen Corporation (Gifu, Japan) or Yamagishi farm (Mie, Japan). For gene misexpression using retroviral vectors, line-M White Leghorn eggs were supplied by Nippon Institute for Biological Science (Kobuchizawa, Japan). Eggs were incubated at 38.5°C, and embryos were staged according to Hamburger and Hamilton (1951) .
Isolation of chicken Six2 cDNA
RT-PCR was performed using RNA isolated from St. 35 limbs. A 347 bp Six2 cDNA fragment was obtained by PCR using degenerate primers designed based on the amino acid sequences conserved between murine Six1 and Six2 proteins. To isolate cDNAs corresponding to the 5′ and 3′ regions of Six2, 5′ RACE and 3′ RACE were performed. The chicken Six2 cDNA sequence was deposited in DDBJ (accession No.AB199732). See Suppl. Data for the sequence of PCR primers.
RNA probes
Antisense riboprobes were labeled with digoxigenin or fluorescein. For the chicken Six2 probe, the fragment corresponding to position 638-941 of the DDBJ sequence (accession no. AB199732) was isolated by PCR. For detection of endogenous chicken and virally expressed Hoxa-13 mRNA, an RNA probe was synthesized by using a cDNA clone (Yamamoto and Kuroiwa, 2003) or the SpeIBamHI fragment of this cDNA. A probe for endogenous Hoxa-13 alone was synthesized by using a 330 bp 3′ UTR fragment amplified by PCR from a genomic clone (Yokouchi et al., 1991a) . Chicken Noggin, Bmp-7, Wnt3 and mouse Scx cDNA fragments were isolated by PCR based on NCBI sequence data (Chicken Noggin, Bmp-7 and mouse Scx) or chicken genome database sequences (Chicken Wnt3). Mouse Noggin, Gremlin and Six2 genomic DNA fragments were isolated by PCR. Chicken Scx was provided by Dr. C. J. Tabin. Other probes were described previously: PG-H, LTR (Yokouchi et al., 1995a) , chicken Pax7 (Kawakami et al., 1997) , chicken Bmp-2 and Bmp-4 (Yokouchi et al., 1996) , chicken Tenomodulin (Shukunami et al., 2006) and chicken Hoxd-13 (Yokouchi et al., 1991a) .
In situ hybridization (ISH) and immunofluorescence
Whole-mount in situ hybridization (WISH) was performed following Dietrich et al. (1997) , with minor modifications. Some embryos were sectioned by vibratome after WISH. Section in situ hybridization (SISH) was performed following Braissant and Wahli (1998) , with the following modifications: embryos were incubated with PBS containing 30% sucrose at 4°C overnight, embedded in O. C.T. compound (Sakura Finetechnical Co. Ltd., Japan), frozen, and sectioned at 10-20 µm thickness. The hybridization solution was described previously (Harland, 1991) . Prehybridization and hybridization were carried out at 65°C and 70°C, respectively. For wash steps, solution-X (Dietrich et al., 1997) was used instead of SSC. Wash steps were performed at 70°C. To detect Pax7 protein after SISH, the Sigma Fast ™ Fast Red TR/Naphthol AS-MX Tablet Set (Sigma) was used for the color development reaction of SISH, and mouse monoclonal anti-Pax7 IgG (DSHB) and biotinylated horse anti-mouse IgG (Vector) were used as the first and second antibody, respectively. Streptavidin, Alexa Fluor™ 488 conjugate (Molecular Probes) was used for detection.
Surgical manipulations
For ectopic cartilage formation, incisions were made in the third interdigital zone along digit III and IV of St. 28-30 hindlimb as previously described (Omi and Ide, 1996) , and embryos were harvested 4 days later. For cartilage graft preparation, the sternal cartilage of St. 45 embryo was separated from the sternal perichondrium and thoracic muscles. A piece of the cartilage (approximately 400 µm diameter) was implanted into St. 19-22 host distal limb. Ectoderm removal was performed as previously described (Yang and Niswander, 1995) . To prevent myogenic cell migration into the limb bud, after making a slit along the proximal margin of the presumptive hindlimb level somatopleura of St. 16-17 embryo, a piece of Nuclepore Membrane (pore size 0.2 µm; Whatman) was inserted between the intermediate mesoderm and somatopleural mesoderm. Cartilage-grafted, ectoderm-removed and barrierinserted limbs were fixed when their contralateral control limbs reached St. 26, 31 and 26-27, respectively.
Local applications of proteins
Affi-Gel Blue Gel agarose beads (Bio-Rad) were washed (Storm and Kingsley, 1999) and soaked in 0.1% BSA in PBS containing 700 µg/ ml recombinant mouse Noggin/Fc chimera (R&D systems), 1 mg/ml recombinant human BMP-2 (R&D systems) or 2 mg/ml recombinant mouse sFRP-2 (R&D systems) and incubated on ice. 0.1% BSA in PBSsoaked beads were used as negative controls. A Noggin-soaked bead was grafted to interdigit II of St. 28-29 hindlimb. The embryos were harvested 24 h after grafting. For BMP-2 bead grafts, to minimize injury to the ectoderm, a shallow hole was made with a needle on the dorsal side of a St. 26-27 metatarsal III proximal tip, and a bead was grafted. The embryos were harvested 10 h after grafting. For sFRP-2 bead grafts, a shallow hole was made on the dorsal side of a St. 24-25 autopod, and a bead was grafted. The embryos were harvested 24 h after grafting.
Gene misexpression
Chicken Wnt6 Coding DNA Sequence (CDS) (DDBJ accession no. AB199733) was isolated by PCR and 3′ RACE by referring to the chicken genome database sequence (see Suppl. Data for the sequence of PCR primers). Mouse Wnt3 CDS was isolated by PCR by referring to the NCBI sequence (NM_009521). The sequences around the first ATG codons of cWnt6, mWnt3 and cHoxa-13 full CDSs were modified to be NcoI-compatible sequences by PCR, and then each CDS was connected to the NcoI site of the internal ribosomal entry site (IRES) of pCITE or pCITE2a (Novagen). IRES-CDS fragments was inserted to the ClaI site of RCAS-BP(A). RCASmWnt3a and RCAS-mWnt7a were previously described (Kengaku et al., 1998) . These plasmids were used to transfect chicken embryonic fibroblasts (CEF) by lipofection. CEF culture, collection and concentration of culture media were performed following Yokouchi et al. (1995a) . RCAS-IRES-cHoxa-13 was injected into the presumptive hindlimb region of St. 9-12 embryos (Yokouchi et al., 1995a) , and embryos were fixed when their contralateral limb reached St. 26-27. Each of Wnt viruses or a mixture of RCASmWnt3a and RCAS-IRES-cHoxa-13 was injected into St. 18-20 hindlimb buds, and the embryos were fixed when control limbs reached St. 29-30. pCAGGS constructions and electroporation were performed as described in the caption of Suppl. Fig. 7 . . At St. 30, Six2 expression was extended distally along the digits. At St. 36, Six2 was expressed in the dorsal tissues connected to the zeugopodal extensor muscles (EDL, yellow arrows; EHL, red arrowheads) and to the autopodal muscles (EB3, white arrows; AB2, white arrowheads). In addition, Six2 expression was observed in the ventral tissues connected to the zeugopodal flexor muscles (FPs, FPPs, FDL). Abbreviations: EDL, extensor digitorum longus; EHL, extensor hallucis longus; EB3, extensor brevis digiti III; AB2, abductor digiti II; FP, flexor perforates; FPP, flexor perforans et perforates; FDL, flexor digitorum longus (Baumel et al., 1993) . (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Results
Six2 is a marker of the limb tendon precursor and differentiated tendon
In chick hindlimb, Six2 mRNA was first detected at St. 23-24 in the posterior region of the presumptive autopod, in the presumptive zeugopod and in the pelvic region (Fig. 1A) . From St. 24 to 28, the autopodal expression domain expanded anteriorly (Fig. 1A, arrowhead) . Autopodal expression was restricted to the sub-ectodermal mesenchyme on both dorsal and ventral sides (Fig. 1B, B′) but not observed in the mesenchyme adjacent to the AER (apical ectodermal ridge) ( Fig. 1A and B) . In the zeugopod, two linear expression domains were observed from St. 25 to 28 (Fig. 1A , black arrows). When examined in crosssection, these Six2 expression domains were found to be at the anterior/posterior edges of the dorsal/ventral muscle masses (Fig. 1C, arrows) . In addition, weak expression was observed in the muscle masses themselves (Fig. 1C) . At the anterior/posterior edges of muscle masses, Six2 was expressed in both Pax7-positive and Pax7-negative cells ( Fig. 1D and E), indicating that Six2 was expressed in both muscle precursor cells and mesenchymal cells in the limb. At St. 30, autopodal Six2 expression extended distally along the digits but never observed in the interdigital mesenchyme (Fig. 1F) . Finally, at St. 36, Six2 expression was observed in the tissues connected to the distal dorsal Autopodal expression of Six2 and Hoxa-13 was overlapping, and shared the same proximal boundary (arrows) at the autopod-zeugopod border. fi, fibula; t, tarsal; mt, metatarsal. Proximal is on the left, dorsal is on the top. muscles including EDL (Fig. 1F, yellow arrows. See Fig. 1 caption for abbreviations), EHL (red arrowheads), EB3 (white arrow) and AB2 (white arrowhead). Six2 was also expressed in the tissues connected to the distal ventral muscles, including FPs, FPPs and FDL (Fig. 1F) . On the ventral side of the digits, Six2 expression domains were bifurcated at the digital joints (Fig. 1F ). This morphology is typical of the tendon insertions of the "perforatus (perforated)" muscles: e.g., FPs and FPPs (Baumel et al., 1993) . A similar expression profile was observed in the chick forelimb (Suppl. Fig. 1 ). The morphological features of the Six2 expression domains observed at St. 36 suggest the possibility that Six2 labels the limb tendons.
Tenomodulin is a marker of the differentiated tendon (Shuk unami et al., 2006) . At St. 32, the Six2 expression pattern was identical to that of the Tenomodulin (Fig. 2A) , indicating that Six2 is specifically expressed in the differentiated tendon. We then compared Six2 expression to that of Scx, a marker of the tendon precursor and tendon (Schweitzer et al., 2001 ). After St. 26, Six2 expression overlapped that of Scx in the metatarsal region and in the zeugopod (arrowheads and arrows in Fig. 2B and C, respectively), except that the distal boundary of the metatarsal expression domain of Six2 was less expanded distally than that of Scx (arrowheads in Fig. 2B and C) . The overlapping expression of Six2 and Scx indicates that Six2 is also a marker for the tendon precursor in chick limb after St. 26. We therefore next analyzed the mechanism controlling limb tendon precursor formation by focusing on the regulation of Six2 expression.
Cartilage and BMP antagonist induce mesenchymal Six2 expression
Autopodal cartilage formation progresses in the proximal-todistal and posterior-to-anterior sequences. Extension of the autopodal Six2 expression domain followed autopodal cartilage formation (Fig. 3A) , suggesting that the limb cartilage may induce Six2 expression in the neighboring mesenchyme. To test this possibility, we examined the effect of ectopically formed or grafted cartilage on Six2 expression.
After making incisions between digits and interdigital tissue, ectopic digits with phalangeal cartilage are formed from the residual interdigital mesenchyme (Omi and Ide, 1996) (Fig. 3B and C). In the ectopic digits, Six2 was expressed between the ectoderm and the phalangeal cartilage (Fig. 3C′, D , n ¼11/14). The Six2 expression domains in the ectopic digit had morphological features very similar to those of normal digit. The dorsal ectopic expression domain was a single linear domain (Fig. 3C′ , E, white arrows), and on the ventral side, a single linear expression domain ( Fig. 3D and E, black arrows) was bifurcated at the digital joints ( Fig. 3D and E, arrowheads) .
We then analyzed whether the effect of cartilage in Six2 induction is direct. For this purpose, we grafted a piece of sternum cartilage into the limb. In the grafted limbs, ectopic Six2 expression was observed around the graft (Fig.3F and G, n¼ 3/4) . The ectopic Six2 expression was restricted to the mesenchyme located between the graft and dorsal ectoderm (Fig. 3H) . These results suggest that the cartilage induces mesenchymal Six2 expression via diffusible factor(s).
A BMP antagonist, Noggin, is expressed in the cartilage (Brunet et al., 1998; Capdevila and Johnson, 1998; Merino et al., 1998; Pathi et al., 1999) . We examined the possibility that Noggin can induce Six2 expression. As shown in Fig. 4A , local application of Noggin with Noggin-soaked beads resulted in ectopic Six2 induction in the interdigital mesenchyme around the bead (n¼6/6). Next we tested BMP function by grafting a bead soaked in BMP-2 solution into the dorsal side of the metatarsal III proximal tip, where Six2 is expressed. At 10 h after grafting, Six2 expression disappeared around 1 mg/ml BMP-2-soaked bead (Fig. 4B, n ¼5/7) .
Administration of BMP is known to induce apoptosis of limb bud mesenchyme cells. However, at 10 h after grafting, we did not observe an increase in cell death around the grafted bead soaked with 1 mg/ml BMP-2 solution (Suppl. Fig. 2) , suggesting that the observed disappearance of Six2 expression is not due to apoptosis. Therefore, our results indicate that BMP represses Six2 expression, and that cartilage expressing Noggin induces mesenchymal Six2 expression in the limb by antagonizing BMP signaling.
Ectoderm and Wnts are positive regulators of Six2 expression
Mesenchymal Six2 expression was always found between the cartilage and the ectoderm, indicating that limb ectoderm may be involved in regulating Six2 expression. To test this possibility, we examined Six2 expression after the partial removal of the limb ectoderm. As shown in Fig. 4C , surgical removal of the dorsal ectoderm resulted in the loss of Six2 expression in the underlying mesenchyme (n ¼2/2). Similarly, ventral ectoderm removal resulted in the loss of ventral Six2 expression (n ¼2/2. data not shown (Dealy et al., 1993) and Wnt3 (Suppl. Fig. 3 ) are specifically expressed in the limb ectoderm. In order to test the possibility that Wnts are involved in the regulation of Six2 expression in the limb, we analyzed the effect of local application of a secreted Frizzled-related protein, sFRP-2. sFRP-2 is a potent inhibitor of Wnts, including Wnt6 and Wnt7a (Amura et al., 2005; Yoshioka et al., 2012) . As shown in Fig. 4D , grafting of sFRP-2-soaked beads resulted in the repression of autopodal Six2 expression (n ¼8/11), and we did not observe an increase in cell death around the bead soaked with sFRP-2 (Suppl. Fig. 2 ), suggesting that ectodermal Wnts are positive regulators of Six2 expression.
To ascertain whether ectodermal Wnts function as positive regulators of Six2 expression, we misexpressed Wnt3a via replication-competent retrovirus vector RCAS-BP(A) (Petropoulos and Hughes, 1991) . In the non-infected contralateral autopods at St. 30, metatarsal cartilage formed normally (Fig. 5A) , and no change in Noggin expression was observed (data not shown). Six2 expression in the dorsal/ventral mesenchyme and muscle masses was also unaffected (Fig. 5A) . In contrast, in the RCAS-Wnt3a-injected limbs, cartilage was completely lost (Fig. 5B) , and Noggin expression was never observed (data not shown). For this reason, it was difficult to distinguish the autopod from the zeugopod based on anatomical features of cartilage. Therefore, we discriminated between these two compartments using autopod-specific Hoxa-13 expression as an indicator (Fig. 5B and C) . In the Wnt3a-misexpressing autopods, Six2 was expressed in the muscle mass and in the entire mesenchyme, except cells adjacent to the AER (Fig. 5B , blue arrow, n ¼5/5). In contrast to the results for the autopods, in the Wnt3a-misexpressing zeugopods, Six2 expression was never detected in the mesenchyme and was restricted to the muscle precursor cells (Fig. 5C, n¼5/5 ). Similar to misexpression of Wnt3a, viral misexpression of Wnt6, Wnt7a, and Wnt3 caused partial loss of the autopodal cartilage and ectopic Six2 expression in an area located far from the ectoderm in the autopod (Suppl .  Fig. 4) . These results indicate that Wnt signaling can activate Six2 expression.
Interestingly, in the RCAS-Wnt3a-injected limbs, ectopic Six2 expression occurred in the autopodal mesenchyme, despite the absence of cartilage and an unaltered Bmp expression level (Suppl. Fig. 5 ), but never in the zeugopodal mesenchyme. The different responses of the autopod and zeugopod allow us to hypothesize that autopod-specific factor(s), besides Noggin, cancel(s) BMP signaling to activate Six2 expression. Since Hoxa-13 and Hoxd-13 were likely candidates for the autopod-specific factors, we analyzed the effects of Hoxa-13/Hoxd-13 on Six2 expression.
Hoxa-13/Hoxd-13 misexpression induce ectopic Six2 expression in the zeugopodal mesenchyme located far from cartilage
Prior to the functional analysis of autopodal Hox genes, we compared the expression of Six2 and the Hox genes in the autopod. As shown in Fig. 2D and Suppl. Fig. 6 , Six2 and Hoxa-13 expression were overlapping, and the expression domains of these two genes shared the same proximal expression boundary. In addition, the Six2 expression domain was partially overlapping with that of Hoxd-13 in the distal autopod (Suppl. Fig. 6 ).
In order to analyze autopodal Hox gene function(s) in the regulation of Six2 expression, Hoxa-13 was misexpressed in the limb mesenchyme using RCAS-IRES-Hoxa-13. In the Hoxa-13-misexpressing limbs at St. 26-27, autopodal Six2 expression was not affected (Fig. 6A , n ¼0/17). On the other hand, in the zeugopods, ectopic Six2 expression was observed (Fig. 6A , arrows, n ¼9/17). In the contralateral control zeugopods, Six2 expression was restricted to the muscle mass and to the mesenchyme adjacent to the edges of the muscle mass (Fig. 6B ). In the Hoxa-13-misexpressing zeugopods, ectopic Six2 expression was found in the area located between the muscle mass and the ectoderm (Fig. 6B, blue arrows) . This zeugopodal ectopic Six2 expression was also caused by subectodermal introduction of pCAGGS-Hoxa-13 or -Hoxd-13 using electroporation (Suppl. Fig. 7, arrows) , suggesting redundant functions for Hoxa-13 and Hoxd-13.
There are two possible explanations for the ectopic Six2 expression in Hoxa-13/Hoxd-13-misexpressing zeugopods. One is that Six2 misexpression was induced in the zeugopodal mesenchyme itself, and the other is migration of the Six2-expressing autopodal mesenchymal cells into the zeugopod. To discriminate between these possibilities, we detected endogenous Hoxa-13-expressing cells using a Hoxa-13 3′ UTR probe to mark the original autopodal mesenchymal cells. As shown in Fig. 6C and D, in the Hoxa-13-misexpressing zeugopod, ectopic Six2-expressing cells, located between the ventral muscle mass and ectoderm (Fig. 6C, arrow) , did not express endogenous Hoxa-13 (Fig. 6D, arrow) . Endogenous Hoxa-13 expression was detected only in the autopodal mesenchyme of the same limb (Fig. 6E ). These observations indicate that the induced zeugopodal Six2 expression is not due to the migration of Six2-expressing cells from the autopod, but rather it is due to de novo expression resulting from misexpressed Hoxa-13.
Hoxa-13 is expressed not only in the autopodal mesenchyme but also in restricted parts of the muscle masses in developing limb (Yamamoto et al., 1998) . Thus, the induction of ectopic Six2 expression in Hoxa-13-misexpressing limbs may reflect two distinct Hoxa-13 functions-one in the autopodal mesenchyme and the other in the muscle mass. To test the possibility that Hoxa-13-misexpressing muscle mass interacts with the zeugopodal mesenchyme to induce ectopic Six2 expression, Hoxa-13 was misexpressed in the muscleless limb buds. To prevent muscle precursor cell migration from somites to limb bud, we inserted a piece of Nuclepore membrane between the hindlimb-level somatopleural mesoderm and intermediate mesoderm prior to the migration. In the manipulated limbs, cartilage developed normally (our observation), but the dorsal and ventral muscle masses were completely absent (Fig. 6B) . Six2 expression was not changed in the autopod of the muscleless limb (data not shown), and zeugopodal Six2 expression remained in the central regions of the dorsal and ventral mesenchyme (Fig. 6B , black arrows, n ¼2/2), suggesting that zeugopodal Six2 expression is not dependent on interaction with the muscle mass. We then misexpressed Hoxa-13 in the muscleless limb buds and found that ectopic Six2 expression was also detectable in the zeugopodal mesenchyme adjacent to ectoderm (Fig. 6B , green arrows, n ¼2/2). These results indicate that Hoxa-13 affects mesenchymal Six2 expression in a muscle mass-independent manner.
In the Hoxa-13-misexpressing zeugopod, ectopic cartilages develop between two long bone cartilages (Yokouchi et al., 1995a) . It is therefore possible that Hoxa-13 up-regulates Six2 expression by increasing Noggin level through ectopic cartilage formation. To test this possibility, we analyzed Noggin expression in the Hoxa-13-misexpressing zeugopods. In the Hoxa-13-misexpressing hindlimb, Noggin mRNA levels in the tibia and fibula were unaltered (Fig. 6G and data not shown). In this zeugopod, two ectopic cartilages were formed (Fig. 6F, arrow and arrowhead) . The dorsal cartilage (Fig. 6G,  arrow) , but not the ventral cartilage (arrowhead), expressed Noggin. In this zeugopod, ectopic Six2 expression was observed in the mesenchyme located between the ventral muscle mass and the ectoderm (Fig. 6C, arrow) , in spite of the long distance from the Nogginexpressing dorsal ectopic cartilage. This result suggests that Hoxa-13 can up-regulate Six2 expression without increasing the Noggin expression level.
Wnt3a/Hoxa-13 co-misexpression cooperatively induces ectopic Six2 expression in the zeugopodal mesenchyme As already shown in Fig. 6B , ectopic Six2 induction by Hoxa-13 misexpression was restricted to the mesenchyme near the ectoderm. We then tested the possibility that Hoxa-13 cooperates with Wnt signaling. For this purpose, we analyzed Six2 expression in Wnt3a/Hoxa-13 co-misexpressing limb. For the co-misexpression of Wnt3a/Hoxa-13, we injected a mixture of two viruses, RCASWnt3a and RCAS-IRES-Hoxa-13. Interestingly, in the co-injected limb, ectopic Six2 expression was reproducibly observed in mesenchyme located not only in the sub-ectodermal region but also in the central region of the limb (Fig. 7 , arrowheads, n ¼3/3). As already shown, RCAS-Wnt3a alone did not induce any ectopic Six2 expression in the zeugopod (Fig. 5C) , and RCAS-IRES-Hoxa-13 alone induced ectopic Six2 expression only in the sub-ectodermal region (Fig. 6B) . Thus, co-misexpressed Wnt3a enhanced the misexpressed Hoxa-13 function in the induction of Six2 expression. These results indicate that Hoxa-13 cooperates with ectodermal Wnts in the regulation of Six2 expression.
Six2 expression in the dorsal autopod disappears in Hoxa-13
We showed that misexpression of Hoxa-13 induces ectopic Six2 expression. To ask whether autopodal Hox expression is necessary for autopodal Six2 expression, we analyzed Six2 expression in Hox mutant mice. For cartilage formation, Hoxa-13 and HoxD Abd-B family genes show functional redundancy (Fromental-Ramain et al., 1996; Zakany et al., 1997) . Therefore, it is possible that these Hox genes also redundantly regulate Six2 expression. To test this possibility, we used mice doubly mutant for Hoxa-13 and HoxD alleles for functional analysis. HoxD del is a triple loss-of-function allele of Hoxd-13, Hoxd-12 and Hoxd-11 (Zakany et al., 1997) . As in the chicken limb bud, in the mouse forelimb bud, autopodal Six2 expression expanded from posterior to anterior on both dorsal and ventral sides (Suppl. Fig. 8 ). In the Hoxa-13 þ /− ; HoxD del/del or Hoxa-13
;HoxD þ /del autopods at 11.5 dpc (days post-coitum), Six2 expression was not affected (Fig. 8A , n ¼2/2 in each of these genotypes). In contrast, as shown in Fig. 8A and C, Six2 expression on the dorsal side of the autopod was not detected in Hoxa-13
;HoxD del/del mice (n¼2/2). Conversely, ventral autopodal Six2 expression was not significantly affected ( Fig. 8B and C) .
In the Hoxa-13
;HoxD del/del embryos, facial expression of Six2
was not affected (Suppl. Fig. 9 ), indicating that the loss of Six2 expression is specific to the dorsal autopod. ;HoxD del/del autopod at 11.5 dpc (Suppl. Fig. 10 ). Thus, at least the dorsal loss of Six2 expression in the Hoxa-13
;HoxD del/del embryo is not a result of an increase in BMP signal.
Discussion
Tendons develop in the sub-ectodermal region adjacent to cartilage that has formed earlier, suggesting that the ectoderm and cartilage induce tendon formation through secreted molecules determining the differentiation fate of limb mesenchymal cells. Moreover, tendons develop in a position-specific pattern, suggesting that the mechanism that determines the position-specific tissue patterning functions concurrently. We found that Six2 is expressed in the tendon precursor and tendon in the limb. Then we tried to identify the factors that induce Six2 expression in the tendon precursor and determine its position-specific pattern in the autopod.
Cartilage and ectoderm regulate mesenchymal Six2 expression in the distal limb tendon precursor via tissue interactions
In order to analyze the tissue interaction inducing the autopodal tendon precursor, we examined the signaling molecules affecting Six2 expression. Six2 is expressed in the mesenchyme at the dorsal and ventral side of the cartilage, and never expressed in the mesenchyme adjacent to the AER or the interdigital mesenchyme (Fig. 1A, B and F) . BMPs, candidate signaling molecules for the control of Six2 expression, are expressed in both AER and the interdigital mesenchyme (Francis et al., 1994; Macias et al., 1997; Fig. 7 . Co-misexpression of Wnt3a and Hoxa-13 induces ectopic Six2 expression in the zeugopodal mesenchyme distant from the ectoderm. Expression of PG-H, Six2 and Pax7 in serial cross-sections of a zeugopod from an RCAS-Wnt3a/RCAS-IRES-Hoxa-13 co-injected limb. Six2 was ectopically expressed in the mesenchyme located far from the ectoderm (arrowheads). Anterior is on the left, dorsal is on the top. Yokouchi et al., 1996) , and Noggin is expressed in the limb cartilage (Brunet et al., 1998; Capdevila and Johnson, 1998; Merino et al., 1998; Pathi et al., 1999) . We showed that local application of BMP-2 represses Six2 expression (Fig. 4B ) and that Noggin induces ectopic Six2 expression (Fig. 4A) . Moreover, we showed the necessity of the limb ectoderm for underlying Six2 expression (Fig. 4C) . Hence, cartilage-derived Noggin would restrict Six2 expression in the sub-ectodermal mesenchyme adjacent to the cartilages by antagonizing BMP activity. Scx expression is also regulated by BMP, Noggin and the ectodermal signal in the limb bud (Schweitzer et al., 2001 ). In the limb tendon precursor, the Scx expression domain is wider than that of Six2 (Fig. 2B and C) . These findings suggest that Scx and Six2 mark tendon precursor cells at distinct stages of differentiation. On the other hand, at an earlier developmental stage, Scx is not expressed in the mesenchyme of the posterior distal limb bud (Suppl. Fig. 11 ). In contrast, Six2, as well as other tendon/ligament-related genes including Irxl1/Mkx, are expressed in this region (Suppl. Fig. 11 ; Takeuchi and Bruneau, 2007) . This suggests the possibility that this posterior distal mesenchyme also contributes to tendon/ligament cell fate. In addition, non-overlapping expression of Scx and Six2 at an early stage suggests that these genes are regulated independently in the posterior distal mesenchyme. The presence of ectoderm-derived signaling molecules responsible for tendon precursor-specific gene expression regulation has been proposed (Schweitzer et al., 2001 ), but such a molecule has not been identified previously. We showed that application of a Wnt antagonist represses Six2 expression (Fig. 4D ) and that misexpression of Wnt induces Six2 expression in the center of the autopod (Fig. 5B and Suppl. Fig. 4 ) without reducing the Bmp expression level (Suppl. Fig. 5 ). Therefore, mesenchymal cells require not only cartilage expressing Noggin but also ectodermal Wnts for Six2 expression. Considering expression in the limb bud, ectodermal Wnt6 and Wnt7a may mainly function in Six2-expressing tendon precursor formation in the chick limb. Recently, it was reported that loss of function of Wntless and beta-catenin both cause the loss of Scx expression in the limb tendon precursor (Zhu et al., 2012) . Wntless is required for the secretion of various Wnts, and beta-catenin is a crucial mediator of the canonical Wnt pathway. This report supports our finding that ectodermal Wnts are involved in limb tendon precursor-specific gene regulation.
Hoxa-13 and Hoxd-13 regulate autopodal Six2 expression in cooperation with Noggin and Wnts from cartilage and ectoderm
In the Wnt3a-misexpressing limb, ectopic Six2 expression was restricted to the autopod (Fig. 5) , suggesting the involvement of autopod-specific factor(s) in the regulation of Six2 expression. Therefore, it is possible that autopodal Hox genes regulate Six2 expression in the tendon precursor. To answer the question of whether Hox genes are involved in tendon precursor formation, we analyzed the function of Hox genes expressed specifically in the autopodal mesenchyme. We showed that misexpression of either Hoxa-13 or Hoxd-13 in the zeugopodal mesenchyme results in ectopic Six2 expression ( Fig. 6A and B ; Suppl. Fig. 7 ). In addition, dorsal Six2 expression disappeared in the Hoxa-13 −/− ;HoxD del/del autopod (Fig. 8) . These results indicate that autopodal Hox genes regulate Six2 expression in the tendon precursor. Furthermore, our results point to the possibility that Hox genes control positionspecific tendon precursor formation via the regulation of tendon cell fate-specific gene expression.
In the Hoxa-13-misexpressing limb, ectopic Six2 expression was restricted to the mesenchyme near the ectoderm (Fig. 6B) , suggesting the necessity of ectodermal factor(s) for Hox function. To ask about the possible cooperation between autopodal Hox genes and ectodermal Wnt, Wnt3a/Hoxa-13 co-misexpression was performed, and the enhanced ectopic Six2 expression resulted in the zeugopod (Fig. 7) . This result indicates the cooperation of autopodal Hox and ectodermal Wnt in the Six2 expression regulation.
In the Hoxa-13-misexpressing limb, ectopic Six2 expression was restricted to the mesenchyme far from the cartilage (Fig. 6B and C) , where Noggin level is low. Additionally, in the Wnt3a-misexpressing autopod and in the Wnt3a/Hoxa-13-co-misexpressing zeugopod, Six2 is ectopically expressed in the mesenchyme (Fig. 5B and Fig. 7) , where Noggin level is low due to the loss of cartilage. These findings suggest the possibility that autopodal Hox genes can activate Six2 expression despite the low level of Noggin. Interestingly, dorsal Six2 expression was lost in the Hoxa-13
autopod, but ventral expression was not affected (Fig. 8) . Bmp-4 expression in dorsal mesenchyme is more intensive than that in ventral mesenchyme in the chicken limb bud (Geetha-Loganathan et al., 2006) , suggesting higher BMP concentration in the dorsal mesenchyme than in the ventral mesenchyme. Therefore, autopodal Hox genes may function to override a certain level of BMP signaling to permit autopodal Six2 expression. Although Hoxa-13 is expressed in the entire autopodal mesenchyme, Six2 is never expressed in the interdigital mesenchyme or the mesenchyme adjacent to the AER in normal limbs or even in Wnt3a-misexpressing limbs (Fig. 1A , B, and F; Fig. 5B) , where the BMP level is high. In addition, misexpression of Hoxa-13 and co-misexpression of Wnt3a/Hoxa-13 did not induce ectopic Six2 expression in the sub-AER mesenchyme (data not shown). Therefore, the autopodal Hox genes alone are not sufficient to permit Six2 expression in the region that receives high level BMP signaling. It is also possible that negative factors other than BMPs repress Six2 expression in sub-AER mesenchyme, and AER-FGFs are candidates for these negative factors. We tested the effect of AER-FGF, but contrary to our expectation, Six2 expression was enhanced around grafted FGF4-soaked beads (data not shown). Since an Wnt inhibitor, Dkk-1, is expressed in the AER of chick and mouse (Grotewold and Ruther, 2002) , it is possible that input of Wnt signaling is not enough to activate Six2 expression in the sub-AER mesenchyme even in the presence of Hoxa-13 and Hoxd-13. Alternatively, transcription factors specifically expressed in the sub-AER mesenchyme, such as Msx1 (Yokouchi et al., 1991b) , that have activity antagonistic to Hoxa-13 and Hoxd-13 (Suzuki et al., 2003) may be involved in the repression of Six2 expression in the sub-AER region.
How do the autopodal Hox genes regulate Six2 expression? In the autopod, the Six2 expression domain overlaps that of Hoxa-13, and they share the same proximal boundary, suggesting that Hoxa-13 may regulate Six2 expression via a cell-autonomous mechanism or via a very short-range intercellular signal. Six2 is a downstream target of several Hox transcription factors. For instance, Hoxa-2 represses Six2 expression in the second branchial arch (Kutejova et al., 2008) . In addition, Hox11 (Hoxa-11, Hoxc-11 and Hoxd-11) directly bind to the regulatory region upstream of the Six2 promoter by forming a complex with Pax2 and Eya1 and activate Six2 expression in the metanephric kidney (Gong et al., 2007; Yallowitz et al., 2009) . Since the Hox11 binding sequence in this region is TTAT and this sequence is also the target of other Abd-B family Hox proteins, including Hox13, it is likely that Hox13 also control Six2 expression by binding this site. However, interestingly, when the enhancer activity of this regulatory region was analyzed in transgenic mice, expression of the reporter gene recapitulated Six2 expression in the branchial arch, otic region, and urogenital mesoderm, but not in the tendon precursor of the limb bud (Gong et al., 2007) . This indicates that Hox13-dependent Six2 enhancer activity in the tendon precursor is independent from this region. Alternatively, Hox13 bind to the same site as Hox11, but for transcriptional activation, Hox13 interact with a yet unidentified tendonspecific enhancer located elsewhere. Our transgenic mouse analysis using a BAC clone encompassing a region 157 kb upstream and 41 kb downstream from the transcription start site of Six2 resulted in the same expression pattern as in the report by Gong et al. (2007) and failed to recapitulate the tendon precursor expression (our unpublished results). This indicates that the Hox13-dependent tendon enhancer of Six2 is located far from the transcription start site.
Another possibility in the regulation of Six2 by Hox genes is that they modulate the function(s) of receptor-regulated Smads (RSmads), the effectors of BMP and Tgf-beta/Activin signaling. Hoxa-13 and Hoxd-13 interact with the MH2 domain of R-Smads, including two BMP-regulated Smads, Smad5 and Smad1, and antagonize Smad-mediated transcriptional activation (Williams et al., 2005) . It is possible that these molecular interactions found in yeast and cultured mammalian cells explain the repression of BMP signaling by Hoxa-13 and Hoxd-13 in Six2 regulation in the limb mesenchyme.
